Dr Sheng Oon
Clinical (Lecturer)
The Sir Peter MacCallum Department of Oncology
28 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma
DOI: 10.1111/bju.168432024
Journal article
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study
DOI: 10.1016/j.eururo.2023.08.0262024
Journal article
Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer
DOI: 10.1186/s13014-024-02413-w2024
Journal article
Intra-articular hyaluronic acid and platelet-rich plasma as monotherapy or combination therapy in knee osteoarthritis?
DOI: 10.1080/17460751.2024.24392212023
Conference Proceedings
LuTectomy: phase 1/2 study evaluating dosimetry, safety and potential benefit of pre-surgery [177Lu]Lu-PSMA-617 radioligand therapy in patients with high-risk localised prostate cancer
2023
Conference Proceedings
Salvage radical prostatectomy following 177Lu-PSMA-617 radioligand therapy in men with high-risk localized prostate cancer: Surgical aspects of the LuTectomy study
DOI: 10.1016/s0302-2838(23)01438-02023
Journal article
Metabolic and magnetic resonance imaging: complementary modalities for the preoperative assessment of lateral pelvic lymph nodes in rectal cancer
DOI: 10.1111/ans.18020
RECENT SCHOLARLY WORKS
2021
Journal article
Evaluation of the Impact of Magnetic Resonance Imaging with Susceptibility-weighted Imaging for Screening and Surveillance of Radiation-induced Cavernomas in Long-term Survivors of Malignancy
DOI: 10.1016/j.clon.2021.04.0102021
Conference Proceedings
Quantitative 68Ga-PSMA-11 PET/CT Parameters of Intraprostatic Malignancy in Men with Prostate Adenocarcinoma in the proPSMA Study: Comparison to ISUP Grade Group
2021
Conference Proceedings
Radiation-induced cavernomas: investigating the role of MRI-SWI for screening and surveillance in long-term cancer survivors
DOI: 10.1016/s0167-8140(21)06824-9